Financials EPS Creative Health Technology Group Limited
Equities
3860
KYG3121P1054
Apparel & Accessories
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 HKD | +4.65% | +4.65% | 0.00% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 235 | 240 | 260 | 475 | 700 | 555 |
Enterprise Value (EV) 1 | 151.7 | 162.4 | 163.5 | 391.8 | 594.4 | 426.6 |
P/E ratio | 16 x | 8.81 x | 11.4 x | 73 x | -39.7 x | -12.1 x |
Yield | 3.19% | 3.33% | - | - | - | - |
Capitalization / Revenue | 0.6 x | 0.55 x | 0.48 x | 1.17 x | 1.65 x | 1.23 x |
EV / Revenue | 0.39 x | 0.37 x | 0.3 x | 0.97 x | 1.4 x | 0.94 x |
EV / EBITDA | 7.56 x | 4.77 x | 4.81 x | 53.4 x | -72.4 x | -11 x |
EV / FCF | 14.4 x | -33 x | 5.65 x | -25.8 x | 20 x | 262 x |
FCF Yield | 6.92% | -3.03% | 17.7% | -3.87% | 4.99% | 0.38% |
Price to Book | 2.55 x | 2.14 x | 2.05 x | 3.57 x | 5.58 x | 6.33 x |
Nbr of stocks (in thousands) | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 |
Reference price 2 | 0.4700 | 0.4800 | 0.5200 | 0.9500 | 1.400 | 1.110 |
Announcement Date | 27/06/18 | 19/06/19 | 24/06/20 | 14/07/21 | 14/07/22 | 28/07/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 390.4 | 433 | 537.4 | 405.4 | 424.7 | 452.9 |
EBITDA 1 | 20.08 | 34.03 | 33.96 | 7.334 | -8.208 | -38.69 |
EBIT 1 | 19.08 | 32.94 | 32.92 | 6.357 | -9.191 | -40.19 |
Operating Margin | 4.89% | 7.61% | 6.13% | 1.57% | -2.16% | -8.87% |
Earnings before Tax (EBT) 1 | 17.31 | 32.72 | 27.8 | 7.136 | -16.62 | -48.16 |
Net income 1 | 14.08 | 27.23 | 22.74 | 6.505 | -17.64 | -45.74 |
Net margin | 3.61% | 6.29% | 4.23% | 1.6% | -4.15% | -10.1% |
EPS 2 | 0.0294 | 0.0545 | 0.0455 | 0.0130 | -0.0353 | -0.0915 |
Free Cash Flow 1 | 10.5 | -4.913 | 28.94 | -15.16 | 29.66 | 1.628 |
FCF margin | 2.69% | -1.13% | 5.39% | -3.74% | 6.98% | 0.36% |
FCF Conversion (EBITDA) | 52.32% | - | 85.21% | - | - | - |
FCF Conversion (Net income) | 74.59% | - | 127.29% | - | - | - |
Dividend per Share 2 | 0.0150 | 0.0160 | - | - | - | - |
Announcement Date | 27/06/18 | 19/06/19 | 24/06/20 | 14/07/21 | 14/07/22 | 28/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 83.3 | 77.7 | 96.5 | 83.2 | 106 | 128 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 10.5 | -4.91 | 28.9 | -15.2 | 29.7 | 1.63 |
ROE (net income / shareholders' equity) | 23.9% | 26.7% | 19.1% | 5.01% | -14.2% | -43.4% |
ROA (Net income/ Total Assets) | 12.6% | 15.6% | 13.6% | 2.57% | -2.87% | -9.59% |
Assets 1 | 111.4 | 175 | 167.2 | 253.4 | 614.2 | 477.1 |
Book Value Per Share 2 | 0.1800 | 0.2200 | 0.2500 | 0.2700 | 0.2500 | 0.1800 |
Cash Flow per Share 2 | 0.1700 | 0.1600 | 0.2000 | 0.1700 | 0.4000 | 0.2600 |
Capex 1 | 1.15 | 2.94 | 0.34 | 0.53 | 0.05 | 2.41 |
Capex / Sales | 0.29% | 0.68% | 0.06% | 0.13% | 0.01% | 0.53% |
Announcement Date | 27/06/18 | 19/06/19 | 24/06/20 | 14/07/21 | 14/07/22 | 28/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 57.45M | |
-11.89% | 751M | |
+22.60% | 405M | |
+127.76% | 223M | |
0.00% | 154M | |
+19.78% | 143M | |
-33.52% | 119M | |
+27.48% | 105M | |
+14.89% | 75.53M | |
-1.15% | 69.82M |
- Stock Market
- Equities
- 3860 Stock
- Financials EPS Creative Health Technology Group Limited